US Labor Department finalizes rule forcing PBMs to disclose fees

· Health · United States

The US Labor Department finalized a sweeping disclosure rule requiring pharmacy benefit managers, the intermediaries that negotiate drug prices between manufacturers, insurers and employers, to share broad fee and compensation data with self-funded employer clients starting in 2027. Employers welcomed the rule, while PBMs criticized it as government overreach. The rule targets payments that are currently kept private, and it lands as drug pricing remains a central political issue in Washington. PBMs sit between drugmakers and payers, and their compensation practices have drawn scrutiny from lawmakers and regulators on both sides. The immediate effect is a new compliance burden for the industry's dominant middlemen and, for employers, a clearer view of where their drug spending goes.

Why it matters：Pharmacy benefit managers control how most US prescription spending is negotiated, so forced fee disclosure could reshape their bargaining power and margins industry-wide.

Key points

  • Disclosure obligations begin in 2027.
  • Employers backed the rule; PBMs called it overreach.
  • The rule covers fee and compensation data now kept private.

Sources (original reporting)

More stories from this day